Cargando…
The analyzation and clinical evaluation of ECLIA and CMIA in the detection of Treponema pallidum
To evaluate the clinical application value of electrochemiluminescence immunoassay analyzer (ECLIA) and chemiluminescent magnetic microparticle immunoassay (CMIA) in the detection of Treponema pallidum (TP). A total of 1225 patients in Peking University Third Hospital was enrolled from June 2014 to...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer Health
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5478324/ https://www.ncbi.nlm.nih.gov/pubmed/28614239 http://dx.doi.org/10.1097/MD.0000000000007139 |
_version_ | 1783244941439270912 |
---|---|
author | Zhou, Jiansuo Liang, Yongming Zhang, Jie Cui, Liyan |
author_facet | Zhou, Jiansuo Liang, Yongming Zhang, Jie Cui, Liyan |
author_sort | Zhou, Jiansuo |
collection | PubMed |
description | To evaluate the clinical application value of electrochemiluminescence immunoassay analyzer (ECLIA) and chemiluminescent magnetic microparticle immunoassay (CMIA) in the detection of Treponema pallidum (TP). A total of 1225 patients in Peking University Third Hospital was enrolled from June 2014 to October 2014. ECLIA and CMIA were applied to detect the serum anti-TP. The positive rate was analyzed. RIBA was taken as a golden standard to evaluate the sensitivity, the specificity, the positive predictive value, the negative predictive value, and the accuracy of ECLIA and CMIA. A correlation analysis between 2 assays was conducted, and that between assay and RIBA. We also evaluate the clinical value of TPPA in the detection of T pallidum. The positive rate of CMIA and ECLIA is 10.63% and 9.89%, respectively, showing no statistically significant difference (P > .05). For CMIA, ECLIA, and TPPA, the sensitivity is 99.16%, 99.16%, and 99.16%, the specificity is 98.99%, 99.82%, and 100%, the positive predictive value is 91.47%, 98.33%, and 100%, the negative predictive value is 99.91%, 99.91%, and 99.91%, the coincidence rate is 99.01% (Kappa = 0.895), 99.75% (Kappa = 0.997), and 99.92% (Kappa = 0.998), respectively. The result shows high correlation between ECLIA and CMIA. Both have high sensitivity and specificity and can be used as screening tests for the diagnosis of T pallidum in common condition. |
format | Online Article Text |
id | pubmed-5478324 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2017 |
publisher | Wolters Kluwer Health |
record_format | MEDLINE/PubMed |
spelling | pubmed-54783242017-06-26 The analyzation and clinical evaluation of ECLIA and CMIA in the detection of Treponema pallidum Zhou, Jiansuo Liang, Yongming Zhang, Jie Cui, Liyan Medicine (Baltimore) 4100 To evaluate the clinical application value of electrochemiluminescence immunoassay analyzer (ECLIA) and chemiluminescent magnetic microparticle immunoassay (CMIA) in the detection of Treponema pallidum (TP). A total of 1225 patients in Peking University Third Hospital was enrolled from June 2014 to October 2014. ECLIA and CMIA were applied to detect the serum anti-TP. The positive rate was analyzed. RIBA was taken as a golden standard to evaluate the sensitivity, the specificity, the positive predictive value, the negative predictive value, and the accuracy of ECLIA and CMIA. A correlation analysis between 2 assays was conducted, and that between assay and RIBA. We also evaluate the clinical value of TPPA in the detection of T pallidum. The positive rate of CMIA and ECLIA is 10.63% and 9.89%, respectively, showing no statistically significant difference (P > .05). For CMIA, ECLIA, and TPPA, the sensitivity is 99.16%, 99.16%, and 99.16%, the specificity is 98.99%, 99.82%, and 100%, the positive predictive value is 91.47%, 98.33%, and 100%, the negative predictive value is 99.91%, 99.91%, and 99.91%, the coincidence rate is 99.01% (Kappa = 0.895), 99.75% (Kappa = 0.997), and 99.92% (Kappa = 0.998), respectively. The result shows high correlation between ECLIA and CMIA. Both have high sensitivity and specificity and can be used as screening tests for the diagnosis of T pallidum in common condition. Wolters Kluwer Health 2017-06-16 /pmc/articles/PMC5478324/ /pubmed/28614239 http://dx.doi.org/10.1097/MD.0000000000007139 Text en Copyright © 2017 the Author(s). Published by Wolters Kluwer Health, Inc. http://creativecommons.org/licenses/by/4.0 This is an open access article distributed under the Creative Commons Attribution License 4.0 (CCBY), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. http://creativecommons.org/licenses/by/4.0 |
spellingShingle | 4100 Zhou, Jiansuo Liang, Yongming Zhang, Jie Cui, Liyan The analyzation and clinical evaluation of ECLIA and CMIA in the detection of Treponema pallidum |
title | The analyzation and clinical evaluation of ECLIA and CMIA in the detection of Treponema pallidum |
title_full | The analyzation and clinical evaluation of ECLIA and CMIA in the detection of Treponema pallidum |
title_fullStr | The analyzation and clinical evaluation of ECLIA and CMIA in the detection of Treponema pallidum |
title_full_unstemmed | The analyzation and clinical evaluation of ECLIA and CMIA in the detection of Treponema pallidum |
title_short | The analyzation and clinical evaluation of ECLIA and CMIA in the detection of Treponema pallidum |
title_sort | analyzation and clinical evaluation of eclia and cmia in the detection of treponema pallidum |
topic | 4100 |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5478324/ https://www.ncbi.nlm.nih.gov/pubmed/28614239 http://dx.doi.org/10.1097/MD.0000000000007139 |
work_keys_str_mv | AT zhoujiansuo theanalyzationandclinicalevaluationofecliaandcmiainthedetectionoftreponemapallidum AT liangyongming theanalyzationandclinicalevaluationofecliaandcmiainthedetectionoftreponemapallidum AT zhangjie theanalyzationandclinicalevaluationofecliaandcmiainthedetectionoftreponemapallidum AT cuiliyan theanalyzationandclinicalevaluationofecliaandcmiainthedetectionoftreponemapallidum AT zhoujiansuo analyzationandclinicalevaluationofecliaandcmiainthedetectionoftreponemapallidum AT liangyongming analyzationandclinicalevaluationofecliaandcmiainthedetectionoftreponemapallidum AT zhangjie analyzationandclinicalevaluationofecliaandcmiainthedetectionoftreponemapallidum AT cuiliyan analyzationandclinicalevaluationofecliaandcmiainthedetectionoftreponemapallidum |